The healthcare landscape is undergoing a significant transformation, and one of the most intriguing developments is the emergence of 'payviders' - hospitals that also own insurance plans. This trend, which has gained momentum over the past two decades, raises a host of questions and concerns. As an analyst, I find this evolution particularly fascinating, as it challenges the traditional separation of healthcare providers and insurers.
The Rise of 'Payviders'
Nearly one-third of hospitals in the US now operate as 'payviders', deciding not only when and how to provide treatment but also when and how much to pay for that treatment for patients enrolled in their insurance plans. This dual role has the potential to streamline healthcare delivery, but it also introduces a complex web of incentives and conflicts of interest.
The Benefits of Integration
One of the primary advantages of this integration is improved communication and coordination between insurers and doctors. When hospitals and insurers are under the same corporate roof, red tape is reduced, and care can be more efficiently managed. Hospitals that own insurance plans argue that this setup motivates doctors to provide high-quality care with less waste, as they are responsible for both patient care and the affordability of the insurance plan.
Research supports this claim, showing that patients with Medicare Advantage plans administered by hospital-owned insurers have better experiences, higher-quality care, and improved coordination. They also require fewer prior authorizations and have lower readmission rates and surgical complications compared to standard Medicare Advantage plans.
Potential Pitfalls
However, this integration also raises concerns. One of the primary issues is the potential for 'payviders' to game the system and extract extra taxpayer money. The government pays Medicare Advantage plans a set amount per enrollee, and this money is used to cover healthcare costs. Through risk adjustment, the government pays more for enrollees with more health diagnoses, as they typically have higher medical costs.
Past studies suggest that enrolling in a hospital-owned plan can increase an individual's number of diagnoses, indicating that some hospitals may encourage their doctors to record more diagnoses to receive higher government payments. This practice drives up taxpayer costs and raises questions about the integrity of the system.
Additionally, companies that manage both insurance and care could manipulate prices paid to affiliated hospitals, inflating plan costs and skirting medical loss ratio rules to increase profits. Our research found that affiliated Medicare Advantage plan prices are, on average, about 5% higher than unaffiliated plan prices at the same hospital, which could be indicative of gaming or more benign explanations.
Competition and Anti-Competitive Behavior
Another concern is the potential harm to competition. Hospitals that own insurance plans could use their position to make their plans more desirable than competitors, either by charging higher prices or refusing to provide care to enrollees of competing plans. Our findings show that 10% to 20% of hospitals that own insurance plans charge higher prices to competitor Medicare Advantage plans, while 7% to 24% charge lower prices. This suggests a potential anti-competitive behavior that could drive up premiums for enrollees of competing plans.
The Unknowns and Trade-Offs
While we have some evidence of potential gaming and anti-competitive behavior, much remains unknown about the long-term effects of hospital-insurance integration. Our research has found that Medicare Advantage plans owned by hospitals charge higher premiums, but we haven't yet determined how much of this is due to higher quality care versus anti-competitive practices.
As with any significant change, this integration comes with trade-offs and unknowns. However, as we continue to study and understand these dynamics, both patients and policymakers can make more informed decisions about the trade-offs involved. The healthcare system is evolving, and it's crucial to stay vigilant and analytical to ensure that these changes benefit patients and society as a whole.
